Literature DB >> 16782036

Interplay between RORgammat, Egr3, and E proteins controls proliferation in response to pre-TCR signals.

Hongkang Xi1, Ruth Schwartz2, Isaac Engel3, Cornelis Murre2, Gilbert J Kersh4.   

Abstract

The response of thymocytes to pre-T cell receptor (pre-TCR) signaling includes proliferation and gene rearrangement, two cellular processes that are incompatible. The control of proliferation by pre-TCR signals depends on the activities of the transcription factors RORgammat, Egr3, E12, and E47. Here, we describe a regulatory network in which interplay between these factors ensures transient proliferation that is temporally distinct from gene rearrangement. RORgammat expression was elevated after pre-TCR signaling, and RORgammat promoted gene rearrangement in CD4+, CD8+ cells by inhibiting cell division, promoting survival via Bcl-X(L), and inducing Rag2. Egr3 was transiently induced by pre-TCR signals and promoted a distinct proliferative phase by reducing E protein-dependent RORgammat expression and interacting with RORgammat to prevent induction of target genes. After Egr3 subsided, the expression and function of RORgammat increased. Thus, transient induction of Egr3 delays the effects of RORgammat and enables pre-TCR signaling to induce both proliferation and gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782036     DOI: 10.1016/j.immuni.2006.03.023

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  54 in total

Review 1.  Tenuous paths in unexplored territory: From T cell receptor signaling to effector gene expression during thymocyte selection.

Authors:  Lie Wang; Yumei Xiong; Rémy Bosselut
Journal:  Semin Immunol       Date:  2010-10       Impact factor: 11.130

Review 2.  Determining γδ versus αß T cell development.

Authors:  Maria Ciofani; Juan Carlos Zúñiga-Pflücker
Journal:  Nat Rev Immunol       Date:  2010-08-20       Impact factor: 53.106

3.  Stage-specific functions of E-proteins at the β-selection and T-cell receptor checkpoints during thymocyte development.

Authors:  Mary Elizabeth Jones; Yuan Zhuang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 4.  Decision checkpoints in the thymus.

Authors:  Andrea C Carpenter; Rémy Bosselut
Journal:  Nat Immunol       Date:  2010-07-20       Impact factor: 25.606

Review 5.  β-catenin/TCF-1 pathway in T cell development and differentiation.

Authors:  Jian Ma; Ruiqing Wang; Xianfeng Fang; Zuoming Sun
Journal:  J Neuroimmune Pharmacol       Date:  2012-04-27       Impact factor: 4.147

Review 6.  Molecular mechanisms that control mouse and human TCR-alphabeta and TCR-gammadelta T cell development.

Authors:  Tom Taghon; Ellen V Rothenberg
Journal:  Semin Immunopathol       Date:  2008-10-17       Impact factor: 9.623

Review 7.  Towards a molecular understanding of the differential signals regulating alphabeta/gammadelta T lineage choice.

Authors:  Sang-Yun Lee; Jason Stadanlick; Dietmar J Kappes; David L Wiest
Journal:  Semin Immunol       Date:  2010-05-14       Impact factor: 11.130

Review 8.  Developmental gene networks: a triathlon on the course to T cell identity.

Authors:  Mary A Yui; Ellen V Rothenberg
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

9.  Pre-TCR signaling inactivates Notch1 transcription by antagonizing E2A.

Authors:  Yumi Yashiro-Ohtani; Yiping He; Takuya Ohtani; Mary E Jones; Olga Shestova; Lanwei Xu; Terry C Fang; Mark Y Chiang; Andrew M Intlekofer; Stephen C Blacklow; Yuan Zhuang; Warren S Pear
Journal:  Genes Dev       Date:  2009-07-15       Impact factor: 11.361

10.  Marked induction of the helix-loop-helix protein Id3 promotes the gammadelta T cell fate and renders their functional maturation Notch independent.

Authors:  Jens Peter Holst Lauritsen; Gladys W Wong; Sang-Yun Lee; Juliette M Lefebvre; Maria Ciofani; Michele Rhodes; Dietmar J Kappes; Juan Carlos Zúñiga-Pflücker; David L Wiest
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.